Although cellular senescence acts primarily as a tumour suppression mechanism, the accumulation of senescent cells in vivo eventually exerts deleterious side effects through inflammatory/tumour-promoting factor secretion.

By an unbiased high-throughput screening of chemical compounds and a bio-functional analysis, Eiji Hara (Aging Biology, IFReC/RIMD, Osaka University) identify BET family protein degrader (BETd) as a promising senolytic drug.

Commentary(PDF)


Article (External-link)

Contact:

Eiji Hara（Aging Biology）

+81-6-6879-4261
eharabiken.osaka-u.ac.jp

WPI Immunology Frontier Research Center (WPI-IFReC)